|
FAM157A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.09399999999693E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.004200E-04 |
| Normal-vs-Stage2 |
1.307400E-01 |
| Normal-vs-Stage3 |
4.36640000045507E-07 |
| Normal-vs-Stage4 |
4.11769999997258E-06 |
| Stage1-vs-Stage2 |
4.997400E-01 |
| Stage1-vs-Stage3 |
1.660020E-03 |
| Stage1-vs-Stage4 |
2.272300E-02 |
| Stage2-vs-Stage3 |
5.343700E-02 |
| Stage2-vs-Stage4 |
7.256100E-02 |
| Stage3-vs-Stage4 |
9.481400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32259999999318E-05 |
| Normal-vs-AfricanAmerican |
1.177720E-02 |
| Normal-vs-Asian |
4.38860000000485E-05 |
| Caucasian-vs-AfricanAmerican |
9.250200E-01 |
| Caucasian-vs-Asian |
2.457800E-01 |
| AfricanAmerican-vs-Asian |
4.059600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.197500E-03 |
| Normal-vs-Female |
3.83020000005452E-06 |
| Male-vs-Female |
3.839600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.24820000000503E-05 |
| Normal-vs-Age(41-60Yrs) |
2.1284999999982E-05 |
| Normal-vs-Age(61-80Yrs) |
6.842800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.104300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.297000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.901000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.093600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.802600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.408600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.422200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.081600E-02 |
| Classical-VS-Follicular |
4.310800E-01 |
| Classical-VS-Other |
2.127700E-02 |
| Classical-VS-Normal |
3.5801000000002E-05 |
| Tall-VS-Follicular |
5.061700E-02 |
| Tall-VS-Other |
4.959200E-01 |
| Tall-VS-Normal |
1.73394999999354E-05 |
| Follicular-VS-Other |
1.172180E-02 |
| Follicular-VS-Normal |
1.704220E-02 |
| Other-VS-Normal |
1.83221999999761E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.800590E-03 |
| Normal-vs-N1 |
1.4038000000216E-06 |
| N0-vs-N1 |
1.028160E-02 |
|
|
